Hoechst Marion Roussel North American head will be MMD's Peter Ladell following merger.
HOECHST MARION ROUSSEL NORTH AMERICA HEAD LADELL is currently president of Marion Merrell Dow North America, MMD announced June 8. Peter Ladell is a 30-year veteran of MMD, joining Merrell as a sales rep in 1965 and ascending to the North American top spot in 1993 ("The Pink Sheet" June 21, 1993, T&G-12). He is one of four MMD execs named to top-level positions in the company to be formed by the merger of Hoechst and MMD.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth